345 related articles for article (PubMed ID: 32280302)
1. The yin and yang functions of extracellular ATP and adenosine in tumor immunity.
Feng LL; Cai YQ; Zhu MC; Xing LJ; Wang X
Cancer Cell Int; 2020; 20():110. PubMed ID: 32280302
[TBL] [Abstract][Full Text] [Related]
2. Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor-Host Interaction and Therapeutic Perspectives.
de Andrade Mello P; Coutinho-Silva R; Savio LEB
Front Immunol; 2017; 8():1526. PubMed ID: 29184552
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of ecto-nucleoside triphosphate diphosphohydrolase 1 (CD39) involved in regulating extracellular ATP-mediated innate immune responses in Japanese flounder (Paralichthys olivaceus).
Li S; Chen X; Wang N; Li J; Feng Y; Sun J
Mol Immunol; 2019 Aug; 112():10-21. PubMed ID: 31075558
[TBL] [Abstract][Full Text] [Related]
4. ATP and Its Metabolite Adenosine as Regulators of Dendritic Cell Activity.
Silva-Vilches C; Ring S; Mahnke K
Front Immunol; 2018; 9():2581. PubMed ID: 30473700
[TBL] [Abstract][Full Text] [Related]
5. Implications of CD39 in immune-related diseases.
Zeng J; Ning Z; Wang Y; Xiong H
Int Immunopharmacol; 2020 Dec; 89(Pt A):107055. PubMed ID: 33045579
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of CD39 unleashes macrophage antibody-dependent cellular phagocytosis against B-cell lymphoma.
Casey M; Segawa K; Law SC; Sabdia MB; Nowlan B; Salik B; Lee C; Winterford C; Pearson S; Madore J; Dougall WC; Gandhi MK; Nakamura K
Leukemia; 2023 Feb; 37(2):379-387. PubMed ID: 36539557
[TBL] [Abstract][Full Text] [Related]
7. Adenosine can thwart antitumor immune responses elicited by radiotherapy : Therapeutic strategies alleviating protumor ADO activities.
Vaupel P; Multhoff G
Strahlenther Onkol; 2016 May; 192(5):279-87. PubMed ID: 26961686
[TBL] [Abstract][Full Text] [Related]
8. Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity.
Kashyap AS; Thelemann T; Klar R; Kallert SM; Festag J; Buchi M; Hinterwimmer L; Schell M; Michel S; Jaschinski F; Zippelius A
J Immunother Cancer; 2019 Mar; 7(1):67. PubMed ID: 30871609
[TBL] [Abstract][Full Text] [Related]
9. Biomimetic Nanocarriers Guide Extracellular ATP Homeostasis to Remodel Energy Metabolism for Activating Innate and Adaptive Immunity System.
Wu L; Xie W; Li Y; Ni Q; Timashev P; Lyu M; Xia L; Zhang Y; Liu L; Yuan Y; Liang XJ; Zhang Q
Adv Sci (Weinh); 2022 Jun; 9(17):e2105376. PubMed ID: 35396800
[TBL] [Abstract][Full Text] [Related]
10. Adenosine metabolism of human mesenchymal stromal cells isolated from patients with head and neck squamous cell carcinoma.
Schuler PJ; Westerkamp AM; Kansy BA; Bruderek K; Dissmann PA; Dumitru CA; Lang S; Jackson EK; Brandau S
Immunobiology; 2017 Jan; 222(1):66-74. PubMed ID: 26898925
[TBL] [Abstract][Full Text] [Related]
11. Assessment of ATP Metabolism to Adenosine by Ecto-Nucleotidases Carried by Tumor-Derived Small Extracellular Vesicles.
Hong CS; Menshikova EV; Whiteside TL; Jackson EK
Res Sq; 2024 Jan; ():. PubMed ID: 38343828
[TBL] [Abstract][Full Text] [Related]
12. Extracellular ATP and adenosine: The Yin and Yang in immune responses?
Faas MM; Sáez T; de Vos P
Mol Aspects Med; 2017 Jun; 55():9-19. PubMed ID: 28093236
[TBL] [Abstract][Full Text] [Related]
13. The P2X7 Receptor in Tumor Immunity.
Grassi F; De Ponte Conti B
Front Cell Dev Biol; 2021; 9():694831. PubMed ID: 34239877
[TBL] [Abstract][Full Text] [Related]
14. Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death.
Bao X; Xie L
J Exp Clin Cancer Res; 2022 Jul; 41(1):222. PubMed ID: 35836249
[TBL] [Abstract][Full Text] [Related]
15. Extracellular ATP Selectively Upregulates Ecto-Nucleoside Triphosphate Diphosphohydrolase 2 and Ecto-5'-Nucleotidase by Rat Cortical Astrocytes In Vitro.
Brisevac D; Adzic M; Laketa D; Parabucki A; Milosevic M; Lavrnja I; Bjelobaba I; Sévigny J; Kipp M; Nedeljkovic N
J Mol Neurosci; 2015 Nov; 57(3):452-62. PubMed ID: 26080748
[TBL] [Abstract][Full Text] [Related]
16. The adenosinergic machinery in cancer: In-tandem insights from basic mechanisms to therapy.
Kang C; Liu L; Wu C; Li L; Jia X; Xie W; Chen S; Wu X; Zheng H; Liu J; Li R; Zeng B
Front Immunol; 2023; 14():1111369. PubMed ID: 36911717
[TBL] [Abstract][Full Text] [Related]
17. Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation.
Bours MJ; Swennen EL; Di Virgilio F; Cronstein BN; Dagnelie PC
Pharmacol Ther; 2006 Nov; 112(2):358-404. PubMed ID: 16784779
[TBL] [Abstract][Full Text] [Related]
18. Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity.
Li XY; Moesta AK; Xiao C; Nakamura K; Casey M; Zhang H; Madore J; Lepletier A; Aguilera AR; Sundarrajan A; Jacoberger-Foissac C; Wong C; Dela Cruz T; Welch M; Lerner AG; Spatola BN; Soros VB; Corbin J; Anderson AC; Effern M; Hölzel M; Robson SC; Johnston RL; Waddell N; Smith C; Bald T; Geetha N; Beers C; Teng MWL; Smyth MJ
Cancer Discov; 2019 Dec; 9(12):1754-1773. PubMed ID: 31699796
[TBL] [Abstract][Full Text] [Related]
19. Characterization of AB598, a CD39 Enzymatic Inhibitory Antibody for the Treatment of Solid Tumors.
Anderson AE; Parashar K; Jin K; Clor J; Stagnaro CE; Vani U; Singh J; Chen A; Guan Y; Talukdar P; Sathishkumar P; Juat DJ; Singh H; Kushwaha R; Zhao X; Kaplan A; Seitz L; Walters MJ; Fernandez-Salas E; Walker NPC; Bowman CE
Mol Cancer Ther; 2024 May; ():. PubMed ID: 38797955
[TBL] [Abstract][Full Text] [Related]
20. Adenosinergic Signaling as a Key Modulator of the Glioma Microenvironment and Reactive Astrocytes.
Debom GN; Rubenich DS; Braganhol E
Front Neurosci; 2021; 15():648476. PubMed ID: 35069091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
